Mangoceuticals Inc (MGRX) is not a strong buy for a beginner, long-term investor at this time. The lack of positive financial performance, absence of significant trading trends, and no clear technical or proprietary trading signals suggest that this stock does not align with the user's investment goals and risk profile.
The MACD is positive and contracting, RSI is neutral at 44.444, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot level of 0.427, with resistance at 0.494 and support at 0.361. Overall, no clear bullish or bearish signal is present.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
The company's financials show a YoY revenue drop of -10.34%, a significant net income loss of -3063567 (despite improvement YoY), and a sharp EPS decline of -70.27%. No recent news or political trading activity to provide support.
In Q4 2025, revenue decreased by -10.34% YoY, net income improved by 57.24% YoY but remains negative, EPS dropped significantly by -70.27%, and gross margin improved but remains negative at -1139.43%. Overall, the financials are weak and do not indicate growth.
No analyst ratings or price target changes available.
